Vectibix - Important Safety Information from AMGEN (Ireland) Ltd as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 25/11/2011

 

Problem Or Issue:
Important Safety Information communication from AMGEN (Ireland) Ltd on the changes to the Vectibix SmPC including safety information on the importance of establishing KRAS status prior to treatment with Vectibix.

Vectibix - Important Safety Information from AMGEN (Ireland) Ltd


« Back